Coronary Artery Disease
Conditions
Interventions
None listed
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: 1) Patients willing to provide written informed consent 2) Patients over 20 years old 3) Patients in whom PCI is clinically indicated 4) Patients who meet the criteria for IVL (OCT calcium score >=3)
Exclusion criteria
Exclusion criteria: 1) Culprit lesions in patients with acute coronary syndrome 2) Graft lesions 3) In-stent restenosis lesions 4) Patients with congestive heart failure 5) Patients deemed inappropriate for inclusion by the principal investigators
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| 1) The success rate of making any calcium cracks (>=1) after IVL without any IVL-related complications (primary effectiveness endpoint) 2) 30-day outcomes (cardiac death, target vessel-related myocardial infarction, stent thrombosis, target vessel revascularization)(primary safety endpoint) | — |
Secondary
| Measure | Time frame |
|---|---|
| 1) The success rate of making any calcium cracks (>=1) before stent implantation 2) Comparing the intravascular imaging findings before and after cutting balloon dilatation followed by IVL 3) Incidence rate of IVL-related complications (eg. major dissection and coronary perforation) 4) Factors associated with calcium fracture after IVL (comparison between IVUS and OCT) 5) Frequency of discordant results between OCT- and IVUS-based Ca scoring systems 6) The success rate of achieving the optimal stent expansion (SEI >=90%) 7) Factors associated with suboptimal stent expansion (SEI <90%) 8) The procedural success rate (residual stenosis <50% without any in-hospital events) 9) 1-year outcomes (cardiac death, target vessel-related myocardial infarction, stent thrombosis, target vessel revascularization) | — |
Countries
Japan
Contacts
Sapporo Cardio Vascular Clinic Cardiovascular Medicine